• Welcome to the new INSPIIRE Portal, click here for a helpful guide to navigate how to login to our new website.

  • Attention Competitive Grant submitters (e.g. ASPIRE):

    To submit a competitive grant proposal please log in on the top right of the Homepage.
    Once you create a proposal please select IIR and then answer yes to the first question "Are applying for a competitive grant".
    You will then see a listing of all current competitive grants available and you may select one.

  • Investigators from RUSSIA: Due to updated privacy law, Russian Investigators must first submit their application to a Pfizer local country office colleague before submitting on the portal.  If you do not have a local country contact, please email [email protected]

  • Please email us at: [email protected] for assistance with INVESTIGATOR INITIATED RESEARCH or COMPOUND TRANSFER REQUESTS  

  • ATTENTION HIV/Maraviroc Requests: Please contact [email protected]  

  • Site is NOT compatible with Safari. Please use IE or Chrome when using this site.  

  • If you applying for grant from Meridian Medical Technologies, please include “MERIDIAN” at the start of your study title so that we can ensure your proposal is routed internally as quickly as possible.

  • If you are interested in submitting an avelumab proposal that includes another Merck Serono product, please submit directly via the Merck Serono portal.  

  • On September 27, 2016, Pfizer completed acquisition of Medivation. In order to allow time for full integration of processes and requirements, Pfizer will not be accepting new IIR/ISR requests for legacy Medivation products until April 1, 2017.